Smokers lungs is a myth
The claim that 'smoker's lungs' is a myth is soundly refuted by extensive medical literature documenting distinct physiological, cellular, and structural damage—such as airway remodeling, antiprotease defects, and endothelial changes—associated with cigarette smoking.
The claim denies the well-established pathological changes occurring in the lungs of smokers ('smokers' lungs'). Multiple retrieved papers (e.g., 1, 2, 3, 4, 11) provide empirical evidence demonstrating specific structural, molecular, and functional alterations in the respiratory systems of smokers compared to nonsmokers. There are no papers supporting the claim that smoker's lungs are a myth. Therefore, the verdict is REFUTED.
Eapen MS, Lu W, Hackett TL, Singhera GK, Mahmood MQ, Hardikar A, Ward C, Walters EH, Sohal SS. Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial-mesenchymal transition.. 2021. https://doi.org/10.1183/23120541.00876-2020
Paper 1 demonstrates distinct small airway remodeling and myofibroblast increases in smokers compared to nonsmoker controls.
See more details
M. D. Wewers, D. J. Herzyk, J. E. Gadek. Comparison of Smoker and Nonsmoker Lavage Fluid for the Rate of Association with Neutrophil Elastase. 1989. https://doi.org/10.1165/ajrcmb/1.5.423
Paper 2 finds that smoking is associated with a specific functional defect in the antiprotease screen of the lower respiratory tract.
Jiang J, Zheng Z, Chen S, Liu J, Jia J, Huang Y, Liu Q, Cheung CY, Sin DD, Yang T, Wang C. Hypoxia inducible factor (HIF) 3α prevents COPD by inhibiting alveolar epithelial cell ferroptosis via the HIF-3α-GPx4 axis.. 2024. https://doi.org/10.7150/thno.99237
Paper 3 shows that cigarette smoking induces regional tissue hypoxia, oxidative damage, and alveolar changes associated with pre-COPD.
P. Bhattarai, Wenying Lu, A. Hardikar, Surajit Dey, A. Gaikwad, A. M. Shahzad, C. Chia, Andrew Williams, G. Singhera, T. Hackett, M. Eapen, S. Sohal. Endothelial to mesenchymal transition is an active process in smokers and patients with early COPD contributing to pulmonary arterial pathology. 2023. https://doi.org/10.1183/23120541.00767-2023
Paper 4 documents endothelial-to-mesenchymal transition and arterial remodeling in smokers and patients with early COPD.
Golnar Sabetian, Mina Ostovan, Simin Azemati, Naeimehossadat Asmarian, Sina Azadikhah, Vida Naderi-boldaji. The Effect of Patients’ Position on Arterial Oxygenation During One-Lung and Two-Lung Ventilation in Thoracic Surgery: Smoker vs. Nonsmoker Patients (A Pilot Study). 2023. https://doi.org/10.5812/mcj-138261
Paper 10 specifically distinguishes physiological measurements and patient cohorts based on a history of smoking versus nonsmoking.
Li J, Liu L, Tang J, He C, Pu G, Sun J. Small Airway Disease in Pre-COPD and Early COPD: Insights Into the Pulmonary "Silent Zone".. 2026. https://doi.org/10.2147/copd.s604789
Paper 11 reviews how smoking and other environmental exposures drive terminal bronchiole loss and small airway disease before overt obstruction develops.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt